Common ownership and market entry in the pharmaceutical industry
Albert Banal-Estañol, Melissa Newham, and Jo Seldeslachts provide evidence on the impact of common ownership on generic drug entry in US pharmaceutical markets.
Albert Banal-Estañol, Melissa Newham, and Jo Seldeslachts provide evidence on the impact of common ownership on generic drug entry in US pharmaceutical markets.
© Barcelona School of Economics. All opinions are the sole responsibility of the authors.
Legal | Cookies
We use cookies to ensure that we offer you the best user experience on our website. If you accept, we understand that you consent to their use. You can always adjust your preferences using the corresponding link.